Table 2.
Hepatic and Renal Biomarkers of the in vivo Toxicity Study Groups
| Vehicle Control (CMC) | CLX | HR1 | HR2 | HR3 | |
|---|---|---|---|---|---|
| AST (U/L) | 150.4 ± 9.53 | 127.5 ± 14 | 148.33 ± 4.66 | 123.33 ± 10.2 | 142 ± 7.37 |
| ALT (U/L) | 32.33 ± 2.73 | 45.66 ± 0.88 | 37.33 ± 5.81 | 35 ± 3 | 37.66 ± 2.33 |
| ALP (U/L) | 125.25 ± 6.56 | 123 ± 6.59 | 120.25 ± 18.9 | 121 ± 11.14 | 102.2 ± 6.36 |
| Total Bilirubin (mg/dL) | 0.05 ± 0.003 | 0.045 ± 0.006 | 0.07 ± 0.005 | 0.065 ± 0.009 | 0.037 ± 0.004 |
| Albumin (g/dL) | 3.72 ± 0.09 | 3.68 ± 0.04 | 3.35 ± 0.17 | 3.61 ± 0.23 | 3.7 ± 0.08 |
| Creatinine (mg/dL) | 0.44 ± 0.056 | 0.43 ± 0.06 | 0.39 ± 0.04 | 0.59 ± 0.06 | 0.53 ± 0.07 |
Notes: Values are expressed as a mean ± SEM; (n = 5), No significant difference was recognized between the groups.